SNGX Hisse Senedi Fiyat Grafiği
SNGX Finansal
Soligenix Inc
$0.42
-70.25%
$-0.99
Kapanışta: Apr 28, 16:00:00 GMT-4
$0.4
-2.75%
$-0.01
Ön Piyasa: Apr 29, 05:58:45 GMT-4
Geri
Soligenix Inc (SNGX) Finansal
Önemli İstatistikler
Önceki Kapanış
$1.41
Açılış fiyatı
$0.6106
Günün Aralığı
$0.3701 - $0.6337
52 haftalık aralık
$0.4093 - $6.23
İşlem hacmi
14.9M
Ort.Hacim
224.2K
Dividend yield
--
EPS (TTM)
-2.76
Piyasa Değeri
$4.2M
SNGX nedir?
Soligenix, Inc. is a late-stage biopharmaceutical company, which engages in the development and commercialization of products to treat rare diseases. The company is headquartered in Princeton, New Jersey and currently employs 14 full-time employees. The Company’s segments include Specialized Biotherapeutics, and Public Health Solutions. Its Specialized BioTherapeutics business segment is engaged in developing and focused on the commercialization of HyBryte (a proposed name of SGX301), a novel photodynamic therapy (PDT), utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL). Its Public Health Solutions segment includes development programs for RiVax, its ricin toxin vaccine candidate and SGX943, its therapeutic candidate for antibiotic-resistant and emerging infectious diseases and its vaccine programs targeting filoviruses (such as Marburg and Ebola) and CiVax, its vaccine candidate for the prevention of COVID-19 (caused by SARS-CoV-2).
